Jeff has over 20 years experience in commercialization and life-cycle management of biopharmaceutical products. As Commercial Strategy lead at InCarda, Jeff is responsible for commercial input into development of InCarda’s lead and pipeline products as well as commercial launch strategy and execution. Prior to InCarda, Jeff was a leader at Jazz Pharmaceuticals in the areas of Life-Cycle Management, New Product Planning and Commercial (Marketing, Analytics, Research). Jeff has worked across a wide range of therapeutics areas from orphan, rare disease to oncology to large cardiovascular conditions. Jeff also worked in commercial roles of increasing levels of responsibility at Gilead Sciences, Schering Plough Pharmaceuticals (now Merck) and management consulting.
Jeff holds a B.A. in Economics from Stanford University (minor in Biology), and an MBA from the UC Berkeley Haas School of Business.